![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
PJ Conn and E Sanders-Bush
Serotonin (5-HT)-stimulated phosphoinositide hydrolysis is mediated by the 5-HT-2 receptor in rat cerebral cortex and by the 5-HT-1c receptor in rat choroid plexus. These systems were used to determine relative efficacies of piperazine derivatives at the 5-HT-2 and 5-HT-1c receptors. Both quipazine and 6-chloro-2-[1-piperazinyl]-pyrazine (MK- 212) stimulated phosphoinositide hydrolysis in cerebral cortex, and these effects were blocked by ketanserin. The maximum responses to these agonists were 80% of the maximum response to 5-HT. m- Trifluoromethylphenylpiperazine (TFMPP), m-chlorophenylpiperazine (MCPP) and 1-(1-naphthyl)-piperazine (1-NP) did not stimulate phosphoinositide hydrolysis in cerebral cortex at concentrations that blocked the effect of 5-HT. In the choroid plexus, TFMPP and MCPP, as well as MK-212 and quipazine, increased phosphoinositide hydrolysis and mianserin blocked these effects. MK-212 had an efficacy which was equal to that of 5-HT, whereas quipazine, MCPP and TFMPP were partial agonists in the choroid plexus. 1-NP did not stimulate phosphoinositide hydrolysis in choroid plexus but completely blocked the effect 5-HT. On the basis of these data, we conclude that quipazine and MK-212 are partial agonists at 5-HT-2 receptors in cerebral cortex, whereas 1-NP, TFMPP and MCPP are pure antagonists of the cortical 5-HT-2 receptor. However, TFMPP and MCPP as well as quipazine and MK-212 are agonists at the 5-HT-1c receptor, while 1-NP is a pure antagonist of the 5-HT-1c receptor in choroid plexus.
This article has been cited by other articles:
|
|
 |
|
  B. Wen, L. Ma, A. D. Rodrigues, and M. Zhu Detection of Novel Reactive Metabolites of Trazodone: Evidence for CYP2D6-Mediated Bioactivation of m-Chlorophenylpiperazine Drug Metab. Dispos., May 1, 2008; 36(5): 841 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-w. Zhang Serotonin Induces Tonic Firing in Layer V Pyramidal Neurons of Rat Prefrontal Cortex during Postnatal Development J. Neurosci., April 15, 2003; 23(8): 3373 - 3384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kim, V. Adipudi, M. Shibayama, S. Giszter, A. Tessler, M. Murray, and K. J. Simansky Direct Agonists for Serotonin Receptors Enhance Locomotor Function in Rats that Received Neural Transplants after Neonatal Spinal Transection J. Neurosci., July 15, 1999; 19(14): 6213 - 6224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rotzinger, J. Fang, and G. B. Baker Trazodone Is Metabolized to m-Chlorophenylpiperazine by CYP3A4 from Human Sources Drug Metab. Dispos., June 1, 1998; 26(6): 572 - 575. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. L. Willins and H. Y. Meltzer Direct Injection of 5-HT2A Receptor Agonists into the Medial Prefrontal Cortex Produces a Head-Twitch Response in Rats J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 699 - 706. [Abstract] [Full Text]
|
|
|
|
 |
|
 M.D. Tricklebank Subtypes of 5-HT receptors J Psychopharmacol, January 1, 1987; 1(4): 222 - 226. [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
